KMT2A and acute lymphoblastic leukemia: These results indicate prolonged exposure to low‐dose decitabine is sufficient to completely deplete MLL‐rearranged ALL cells from DNTM1, however only mildly sensitizes MLL‐rearranged ALL cells toward conventional chemotherapeutics.